Cancer cell membrane coated silica nanoparticles loaded with ICG for tumour specific photothermal therapy of osteosarcoma

Reference

• Da SP, de Freitas ES, Bernegossi J, et al. Nanotechnology-based drug delivery systems for treatment of tuberculosis–a review. J Biomed Nanotechnol. 2016;12:241–260.
   PubMed Web of Science ®Google Scholar
• Wang C, Liu X, Chen S, et al. Facile preparation of phospholipid–amorphous calcium carbonate hybrid nanoparticles: toward controllable burst drug release and enhanced tumour penetration. Chem Commun. 2018;54:13080–13083.
   PubMed Web of Science ®Google Scholar
• Xiong H, Du S, Zhang P, et al. Primary tumour and pre-metastatic niches co-targeting “peptides-lego” hybrid hydroxyapatite nanoparticles for metastatic breast cancer treatment. Biomater Sci. 2018;6:2591–2604.
   PubMed Web of Science ®Google Scholar
• Huang H, Shi H, Liu J, et al. Co-delivery of all-trans-retinoic acid enhances the anti-metastasis effect of albumin-bound paclitaxel nanoparticles. Chem Commun. 2017;53:212–215.
   Web of Science ®Google Scholar
• Wang C, Chen S, Wang Y, et al. Lipase-triggered water-responsive “Pandora’s Box” for cancer therapy: toward induced neighboring effect and enhanced drug penetration. Adv Mater. 2018;30:1706407.
   Web of Science ®Google Scholar
• Zhao X, Tang D, Yang T, et al. Facile preparation of biocompatible nanostructured lipid carrier with ultra-small size as a tumour-penetration delivery system. Coll Surf B: Biointerf. 2018;170:355–363.
   PubMed Web of Science ®Google Scholar
• Song Y, Li Y, Xu Q, et al. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook. IJN. 2016;12:87–110.
   Web of Science ®Google Scholar
• Wei Y, Gao L, Wang L, et al. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy. Drug Deliv. 2017;24:681.
   PubMed Web of Science ®Google Scholar
• Xie X, Li F, Zhang H, et al. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Euro J Pharma Sci. 2016;83:28–35.
   PubMed Web of Science ®Google Scholar
• Chen X, Sun H, Hu J, et al. Transferrin gated mesoporous silica nanoparticles for redox-responsive and targeted drug delivery. Coll Surf B: Biointerf. 2017;152:77.
   PubMed Web of Science ®Google Scholar
• Li X, Zhao W, Liu X, et al. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers. Acta Biomaterialia. 2016;30:378–387.
   PubMed Web of Science ®Google Scholar
• Zhao J, He Z, Li B, et al. AND logic-like pH- and light-dual controlled drug delivery by surface modified mesoporous silica nanoparticles. Mater Sci Eng C Mater Biol Appl. 2017;73:1–7.
   PubMed Web of Science ®Google Scholar
• Tang D, Zhao X, Yang T, et al. Paclitaxel prodrug based mixed micelles for tumour-targeted chemotherapy. RSC Adv. 2018;8:380–389.
   Web of Science ®Google Scholar
• Xiong H, Ni J, Jiang Z, et al. Intracellular self-disassemble polysaccharide nanoassembly for multi-factors tumour drug resistance modulation of doxorubicin. Biomater Sci. 2018;6:2527–2540.
   PubMed Web of Science ®Google Scholar
• Peng S, Wang Y, Li N, et al. Enhanced cellular uptake and tumour penetration of nanoparticles by imprinting the “hidden” part of membrane receptors for targeted drug delivery. Chem Commun. 2017;53:11114–11117.
   PubMed Web of Science ®Google Scholar
• Zhu D, Tao W, Zhang H, et al. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Acta Biomaterialia. 2016;30:144–154.
   PubMed Web of Science ®Google Scholar
• Lin C, Zhang X, Chen H, et al. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumour lineage-homing cell-penetrating peptide. Drug Delivery. 2018;25:256.
   PubMed Web of Science ®Google Scholar
• Xin L, Zhu X, Qiu LJAB. Constructing aptamer anchored nanovesicles for enhanced tumour penetration and cellular uptake of water soluble chemotherapeutics. Acta Biomaterialia. 2016;35:269–279.
   PubMed Web of Science ®Google Scholar
• Yan G, Wang J, Hu L, et al. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles. Acta Biomaterialia. 2017;51:363.
   PubMed Web of Science ®Google Scholar
• Chen Q, Xu L, Liang C, et al. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat Commun. 2016;7:13193.
   PubMed Web of Science ®Google Scholar
• Yang RM, Fu CP, Fang JZ, et al. Hyaluronan-modified superparamagnetic iron oxide nanoparticles for bimodal breast cancer imaging and photothermal therapy. IJN. 2016;12:197–206.
   Web of Science ®Google Scholar
• Zheng T, Li GG, Zhou F, et al. Gold-nanosponge-based multistimuli-responsive drug vehicles for targeted chemo-photothermal therapy. Adv Mater. 2016;28:8218–8226.
   PubMed Web of Science ®Google Scholar
• Gu L, Shi T, Sun Y, et al. Folate-modified, indocyanine green-loaded lipid-polymer hybrid nanoparticles for targeted delivery of cisplatin. J Biomater Sci Polym Ed. 2017;28:690–702.
   PubMed Web of Science ®Google Scholar
• Ding X, Xu X, Zhao Y, et al. Tumour targeted nanostructured lipid carrier co-delivering paclitaxel and indocyanine green for laser triggered synergetic therapy of cancer. RSC Adv. 2017;7:35086–35095.
   Web of Science ®Google Scholar
• Yang N, Ding Y, Zhang Y, et al. Surface functionalization of polymeric nanoparticles with umbilical cord-derived mesenchymal stem cell membrane for tumour-targeted therapy. ACS Appl Mater Interf. 2018;10:22963–22973.
   PubMed Web of Science ®Google Scholar
• Fang RH, Yao J, Fang JC, et al. Cell membrane-derived nanomaterials for biomedical applications. Biomaterials 2017;128:69–83.
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Zhang L, Aryal S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Nat Acad Sci USA. 2011;108:10980–10985.
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Jurado-Sánchez B, et al. Stem cell membrane-coated nanogels for highly efficient in vivo tumour targeted drug delivery. Small 2016;12:4056–4062.
   PubMed Web of Science ®Google Scholar
• Yurkin ST, Wang ZJN. Cell membrane-derived nanoparticles: emerging clinical opportunities for targeted drug delivery. Nanomedicine 2017;12:2007–2019.
   PubMed Web of Science ®Google Scholar
• Xiong H, Wu Y, Jiang Z, et al. pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release, J. Colloid Interface Sci. 2019;536:135–148.
   PubMed Web of Science ®Google Scholar
• Wang C, Han M, Liu X, et al. Mitoxantrone-preloaded water-responsive phospholipid-amorphous calcium carbonate hybrid nanoparticles for targeted and effective cancer therapy. IJN. 2019; 14:1503–1517.
   Web of Science ®Google Scholar
• Suski JM, Magdalena L, Aleksandra W, et al. Isolation of plasma membrane-associated membranes from rat liver. Nat Protoc. 2014;9:312–322.
   PubMed Web of Science ®Google Scholar
• Cao Y, Song J, Ge J, et al. MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7. Oncol Lett. 2018;15:453–458.
   PubMed Web of Science ®Google Scholar
• Wang C, Chen S, Yu Q, et al. Taking advantage of the disadvantage: employing the high aqueous instability of amorphous calcium carbonate to realize burst drug release within cancer cells. J Mater Chem B. 2017;5:2068–2073.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang Z, Zhao X, et al. DOX loaded aggregation-induced emission active polymeric nanoparticles as a fluorescence resonance energy transfer traceable drug delivery system for self-indicating cancer therapy. Acta Biomaterialia. 2019;85:218–228.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Y, Wei M, et al. Cetuximab-modified silica nanoparticle loaded with ICG for tumour-targeted combinational therapy of breast cancer. Drug Deliv. 2019;26:129–136.
   PubMed Web of Science ®Google Scholar
• Meng LX, Ren Q, Meng Q, et al. Trastuzumab modified silica nanoparticles loaded with doxorubicin for targeted and synergic therapy of breast cancer. Artif Cell Nanomed B. 2018;46:S556–S563.
   PubMed Web of Science ®Google Scholar
• Wu L, Ni C, Zhang L, et al. Surface charge convertible and biodegradable synthetic zwitterionic nanoparticles for enhancing cellular drug uptake. Macromol Biosci. 2016;16:308–313.
   PubMed Web of Science ®Google Scholar
• Fang R, Hu C-MJ, Luk BT, et al. Cancer cell membrane-coated nanoparticles for anticancervaccination and drug delivery. Nano Letters 2014;14:2181–2188.
   PubMed Web of Science ®Google Scholar
• Hashemi M, Yadegari A, Yazdanpanah G, et al. Functionalized R9-reduced graphene oxide as an efficient nano-carrier for hydrophobic drug delivery. RSC Adv. 2016;6:74072–74084.
   Web of Science ®Google Scholar
• Sheng Y, Chang L, Kuang T, et al. PEG/heparin-decorated lipid–polymer hybrid nanoparticles for long-circulating drug delivery. Rsc Adv. 2016;6:23279–23287.
   Web of Science ®Google Scholar
• Wang Y, Wang C, Ding Y, et al. Biomimetic HDL nanoparticle mediated tumour targeted delivery of indocyanine green for enhanced photodynamic therapy. Coll Surf B: Biointerf. 2016;148:533–540.
   PubMed Web of Science ®Google Scholar
• Wang C, Bao X, Ding X, et al. A multifunctional self-dissociative polyethyleneimine derivative coating polymer for enhancing the gene transfection efficiency of DNA/polyethyleneimine polyplexes in vitro and in vivo. Polym Chem. 2015;6:780–796.
   Web of Science ®Google Scholar